SOCM
SR One Capital Management Portfolio holdings
AUM
$461M
This Quarter Return
+9.64%
1 Year Return
+23.25%
3 Year Return
+188.96%
5 Year Return
–
10 Year Return
–
AUM
$219M
AUM Growth
+$219M
(+7.1%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Arcellx
ACLX
$3.85B
| $103M | 47.19% |
5,500,007
| – | – |
|
2
Design Therapeutics
DSGN
$315M
| $94.1M | 43.01% |
5,626,476
| – | – |
|
3
Nkarta
NKTX
$151M
| $17.5M | 8.02% |
1,333,333
| – | – |
|
|
EFTR
4
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
| $3.89M | 1.78% |
6,822,114
| – | – |
|